Spring Health valuation, funding and investors
Spring Health works in mental health benefits consulting, based in New York, United States. Founded in 2016, it has about 3,900 employees.
- Last round
- Series E · $100M · Jul 2024
- Valuation at last round
- $3.30B
- Headcount
- 3,898 · up
- Grade
- B
- Founded
- 2016
Spring Health valuation today
VCMC values Spring Health at $4.9B today, with a range of $2.5B to $5.7B and a grade of B. The valuation starts from its last funding round, a Series E round in Jul 2024.
Valuation by date (136 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2016 | $5.51M | $2.00M – $15.1M | $6.60M (+20%) | before first round | – | unknown | D | 0% |
| 1 Feb 2016 | $5.53M | $2.01M – $15.2M | $6.78M (+23%) | before first round | – | unknown | D | 0% |
| 1 Mar 2016 | $5.55M | $2.02M – $15.2M | $6.95M (+25%) | before first round | – | unknown | D | 0% |
| 1 Apr 2016 | $5.57M | $2.03M – $15.3M | $7.14M (+28%) | before first round | – | unknown | D | 0% |
| 1 May 2016 | $5.59M | $2.04M – $15.4M | $7.33M (+31%) | before first round | – | unknown | D | 0% |
| 1 Jun 2016 | $5.61M | $2.04M – $15.4M | $7.53M (+34%) | before first round | – | unknown | D | 0% |
| 1 Jul 2016 | $5.64M | $2.05M – $15.5M | $7.72M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2016 | $5.79M | $2.11M – $15.9M | $7.93M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2016 | $5.94M | $2.16M – $16.3M | $8.15M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2016 | $6.10M | $2.22M – $16.8M | $8.36M (+37%) | before first round | – | unknown | D | 0% |
| 1 Nov 2016 | $6.26M | $2.28M – $17.2M | $8.59M (+37%) | before first round | – | unknown | D | 0% |
| 1 Dec 2016 | $6.43M | $2.34M – $17.7M | $8.81M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jan 2017 | $6.60M | $2.40M – $18.1M | $9.05M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2017 | $6.78M | $2.47M – $18.6M | $9.29M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2017 | $6.94M | $2.53M – $19.1M | $9.52M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2017 | $7.13M | $2.60M – $19.6M | $9.78M (+37%) | before first round | – | unknown | D | 0% |
| 1 May 2017 | $7.32M | $2.67M – $20.1M | $10.0M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jun 2017 | $7.52M | $2.74M – $20.7M | $10.3M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jul 2017 | $7.72M | $2.81M – $21.2M | $10.6M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2017 | $7.93M | $2.89M – $21.8M | $10.9M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2017 | $8.14M | $2.96M – $22.4M | $11.2M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2017 | $8.36M | $3.04M – $23.0M | $11.5M (+37%) | before first round | – | unknown | D | 0% |
| 1 Nov 2017 | $8.58M | $3.12M – $23.6M | $11.8M (+37%) | before first round | – | unknown | D | 0% |
| 1 Dec 2017 | $8.81M | $3.21M – $24.2M | $12.1M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jan 2018 | $9.05M | $3.29M – $24.9M | $12.4M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2018 | $9.29M | $3.38M – $25.5M | $12.7M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2018 | $9.52M | $3.47M – $26.2M | $13.1M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2018 | $9.78M | $3.56M – $26.9M | $13.4M (+37%) | before first round | – | unknown | D | 0% |
| 1 May 2018 | $10.0M | $3.65M – $27.6M | $13.8M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jun 2018 | $10.3M | $3.75M – $28.3M | $14.1M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jul 2018 | $10.6M | $3.85M – $29.1M | $14.5M (+37%) | before first round | – | unknown | D | 0% |
| 13 Jul 2018 | $40.1M | $26.3M – $122M | $80.0M (+100%) | after a round | – | unknown | C | 0% |
| 1 Aug 2018 | $41.5M | $26.3M – $122M | $80.0M (+93%) | after a round | – | unknown | C | 0% |
| 1 Sep 2018 | $44.1M | $26.3M – $122M | $80.0M (+82%) | after a round | – | unknown | C | 0% |
| 1 Oct 2018 | $46.6M | $26.3M – $122M | $80.0M (+72%) | after a round | – | unknown | C | 0% |
| 1 Nov 2018 | $49.5M | $26.3M – $122M | $80.0M (+62%) | after a round | – | unknown | C | 0% |
| 1 Dec 2018 | $52.4M | $26.3M – $122M | $80.0M (+53%) | after a round | – | unknown | C | 0% |
| 1 Jan 2019 | $55.5M | $26.3M – $122M | $80.0M (+44%) | after a round | – | unknown | C | 0% |
| 1 Feb 2019 | $58.9M | $26.3M – $122M | $80.0M (+36%) | after a round | – | unknown | C | 0% |
| 1 Mar 2019 | $62.1M | $26.3M – $122M | $80.0M (+29%) | after a round | – | unknown | C | 0% |
| 1 Apr 2019 | $65.9M | $26.3M – $122M | $80.0M (+21%) | after a round | – | unknown | C | 0% |
| 1 May 2019 | $69.7M | $26.3M – $122M | $80.0M (+15%) | after a round | – | unknown | C | 0% |
| 1 Jun 2019 | $74.0M | $26.3M – $122M | $80.0M (+8%) | after a round | – | unknown | C | 0% |
| 1 Jul 2019 | $78.3M | $26.3M – $122M | $80.0M (+2%) | after a round | – | unknown | C | 0% |
| 1 Aug 2019 | $80.0M | $25.4M – $122M | $80.0M (0%) | after a round | – | unknown | C | 0% |
| 1 Sep 2019 | $80.0M | $24.2M – $122M | $80.0M (0%) | after a round | – | unknown | C | 0% |
| 1 Oct 2019 | $80.0M | $23.0M – $122M | $80.0M (0%) | after a round | – | unknown | C | 0% |
| 1 Nov 2019 | $80.0M | $21.9M – $122M | $80.0M (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2019 | $80.0M | $20.8M – $122M | $80.0M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2020 | $110M | $77.3M – $280M | $198M (+80%) | after a round | – | unknown | C | 0% |
| 2 Jan 2020 | $110M | $77.3M – $280M | $198M (+80%) | after a round | – | unknown | C | 0% |
| 1 Feb 2020 | $115M | $77.3M – $280M | $198M (+71%) | after a round | – | unknown | C | 0% |
| 1 Mar 2020 | $121M | $77.3M – $280M | $198M (+63%) | after a round | – | unknown | C | 0% |
| 1 Apr 2020 | $127M | $77.3M – $280M | $198M (+55%) | after a round | – | unknown | C | 0% |
| 1 May 2020 | $133M | $77.3M – $280M | $198M (+48%) | after a round | – | unknown | C | 0% |
| 1 Jun 2020 | $140M | $77.3M – $280M | $198M (+41%) | after a round | – | unknown | C | 0% |
| 1 Jul 2020 | $147M | $77.3M – $280M | $198M (+34%) | after a round | – | unknown | C | 0% |
| 1 Aug 2020 | $155M | $77.3M – $280M | $198M (+28%) | after a round | – | unknown | C | 0% |
| 1 Sep 2020 | $162M | $77.3M – $280M | $198M (+22%) | after a round | – | unknown | C | 0% |
| 1 Oct 2020 | $171M | $77.3M – $280M | $198M (+16%) | after a round | – | unknown | C | 0% |
| 1 Nov 2020 | $179M | $77.3M – $280M | $198M (+10%) | after a round | – | unknown | C | 0% |
| 19 Nov 2020 | $380M | $268M – $809M | $570M (+50%) | after a round | – | unknown | B | 0% |
| 1 Dec 2020 | $385M | $268M – $809M | $570M (+48%) | after a round | – | unknown | B | 0% |
| 1 Jan 2021 | $399M | $268M – $809M | $570M (+43%) | after a round | 89 | unknown | B | 0% |
| 1 Feb 2021 | $413M | $268M – $809M | $570M (+38%) | after a round | 89 | unknown | B | 0% |
| 1 Mar 2021 | $426M | $268M – $809M | $570M (+34%) | after a round | 89 | unknown | B | 0% |
| 1 Apr 2021 | $441M | $268M – $809M | $570M (+29%) | after a round | 89 | flat | B | 0% |
| 1 May 2021 | $456M | $268M – $809M | $570M (+25%) | after a round | 89 | flat | B | 0% |
| 1 Jun 2021 | $472M | $268M – $809M | $570M (+21%) | after a round | 89 | flat | B | 0% |
| 1 Jul 2021 | $488M | $268M – $809M | $570M (+17%) | after a round | 89 | flat | B | 0% |
| 1 Aug 2021 | $505M | $268M – $809M | $570M (+13%) | after a round | 89 | flat | B | 0% |
| 1 Sep 2021 | $522M | $268M – $809M | $570M (+9%) | after a round | 89 | flat | B | 0% |
| 17 Sep 2021 | $2.0B | $1.7B – $3.0B | $2.6B (+30%) | after a round | 89 | flat | A | 0% |
| 1 Oct 2021 | $2.0B | $1.7B – $3.0B | $2.6B (+29%) | after a round | 89 | flat | A | 0% |
| 1 Nov 2021 | $2.1B | $1.7B – $3.0B | $2.6B (+26%) | after a round | 89 | flat | A | 0% |
| 1 Dec 2021 | $2.1B | $1.7B – $3.0B | $2.6B (+23%) | after a round | 89 | flat | A | 0% |
| 1 Jan 2022 | $2.2B | $1.7B – $3.0B | $2.6B (+20%) | after a round | 89 | flat | A | 0% |
| 1 Feb 2022 | $2.2B | $1.7B – $3.0B | $2.6B (+18%) | after a round | 89 | flat | A | 0% |
| 1 Mar 2022 | $2.3B | $1.7B – $3.0B | $2.6B (+15%) | after a round | 89 | flat | A | 0% |
| 1 Apr 2022 | $2.9B | $1.7B – $4.4B | $3.9B (+35%) | after a round | 540 | growing | B | 0% |
| 1 May 2022 | $3.0B | $1.7B – $4.4B | $3.9B (+28%) | after a round | 540 | growing | B | 0% |
| 1 Jun 2022 | $3.2B | $1.7B – $4.4B | $3.9B (+21%) | after a round | 540 | growing | B | 0% |
| 1 Jul 2022 | $3.4B | $1.7B – $4.4B | $3.9B (+15%) | after a round | 540 | growing | B | 0% |
| 1 Aug 2022 | $3.6B | $1.7B – $4.4B | $3.9B (+9%) | after a round | 540 | growing | B | 0% |
| 1 Sep 2022 | $3.8B | $1.7B – $4.4B | $3.9B (+3%) | after a round | 540 | growing | B | 0% |
| 1 Oct 2022 | $3.9B | $1.8B – $4.4B | $3.9B (0%) | after a round | 540 | growing | B | 0% |
| 1 Nov 2022 | $3.9B | $1.7B – $4.4B | $3.9B (0%) | after a round | 540 | unknown | B | 0% |
| 1 Dec 2022 | $3.9B | $1.7B – $4.4B | $3.9B (0%) | after a round | 540 | unknown | B | 0% |
| 1 Jan 2023 | $4.6B | $2.1B – $5.3B | $4.6B (0%) | after a round | 1,200 | growing | B | 0% |
| 1 Feb 2023 | $4.6B | $2.2B – $5.3B | $4.6B (0%) | after a round | 1,200 | growing | B | 0% |
| 1 Mar 2023 | $4.6B | $2.3B – $5.3B | $4.6B (0%) | after a round | 1,200 | growing | B | 0% |
| 1 Apr 2023 | $4.6B | $2.5B – $5.3B | $4.6B (0%) | after a round | 1,200 | growing | B | 0% |
| 13 Apr 2023 | $2.5B | $2.2B – $3.2B | $2.8B (+10%) | after a round | 1,200 | growing | A | 0% |
| 1 May 2023 | $2.5B | $2.2B – $3.2B | $2.8B (+9%) | after a round | 1,200 | growing | A | 0% |
| 1 Jun 2023 | $2.5B | $2.2B – $3.2B | $2.8B (+9%) | after a round | 1,200 | growing | A | 0% |
| 1 Jul 2023 | $2.6B | $2.2B – $3.2B | $2.8B (+8%) | after a round | 1,200 | growing | A | 0% |
| 1 Aug 2023 | $2.6B | $2.2B – $3.2B | $2.8B (+7%) | after a round | 1,200 | growing | A | 0% |
| 1 Sep 2023 | $2.6B | $2.2B – $3.2B | $2.8B (+6%) | after a round | 1,200 | growing | A | 0% |
| 1 Oct 2023 | $2.7B | $2.2B – $3.5B | $3.0B (+10%) | after a round | 1,800 | growing | A | 0% |
| 1 Nov 2023 | $2.8B | $2.2B – $3.5B | $3.0B (+9%) | after a round | 1,800 | growing | A | 0% |
| 1 Dec 2023 | $2.8B | $2.2B – $3.5B | $3.0B (+7%) | after a round | 1,800 | growing | A | 0% |
| 1 Jan 2024 | $2.9B | $2.2B – $3.5B | $3.0B (+5%) | after a round | 1,800 | growing | A | 0% |
| 1 Feb 2024 | $2.9B | $2.2B – $3.5B | $3.0B (+4%) | after a round | 1,800 | growing | A | 0% |
| 1 Mar 2024 | $3.0B | $2.2B – $3.6B | $3.1B (+2%) | after a round | 2,100 | growing | A | 0% |
| 1 Apr 2024 | $3.1B | $2.2B – $3.6B | $3.1B (+1%) | after a round | 2,100 | growing | A | 0% |
| 1 May 2024 | $3.1B | $2.2B – $3.6B | $3.1B (0%) | after a round | 2,100 | growing | A | 0% |
| 1 Jun 2024 | $3.1B | $2.2B – $3.6B | $3.1B (0%) | after a round | 2,100 | growing | A | 0% |
| 1 Jul 2024 | $3.1B | $2.2B – $3.6B | $3.1B (0%) | after a round | 2,100 | growing | A | 0% |
| 1 Aug 2024 | $3.3B | $2.9B – $4.9B | $4.3B (+30%) | after a round | 2,100 | up | A | 0% |
| 1 Sep 2024 | $3.4B | $2.9B – $4.9B | $4.3B (+27%) | after a round | 2,100 | up | A | 0% |
| 1 Oct 2024 | $3.5B | $2.9B – $4.9B | $4.3B (+24%) | after a round | 2,100 | up | A | 0% |
| 1 Nov 2024 | $3.5B | $2.9B – $4.9B | $4.3B (+22%) | after a round | 2,100 | up | A | 0% |
| 1 Dec 2024 | $3.6B | $2.9B – $4.9B | $4.3B (+19%) | after a round | 2,100 | up | A | 0% |
| 1 Jan 2025 | $3.7B | $2.9B – $4.9B | $4.3B (+16%) | after a round | 2,100 | up | A | 0% |
| 1 Feb 2025 | $3.8B | $2.9B – $4.9B | $4.3B (+14%) | after a round | 2,100 | up | A | 0% |
| 1 Mar 2025 | $3.8B | $2.9B – $4.9B | $4.3B (+12%) | after a round | 2,100 | up | A | 0% |
| 1 Apr 2025 | $3.9B | $2.9B – $4.9B | $4.3B (+9%) | after a round | 2,100 | up | A | 0% |
| 1 May 2025 | $4.0B | $2.9B – $4.9B | $4.3B (+7%) | after a round | 2,100 | unknown | A | 0% |
| 1 Jun 2025 | $4.1B | $2.9B – $4.9B | $4.3B (+4%) | after a round | 2,100 | unknown | A | 0% |
| 1 Jul 2025 | $4.6B | $2.9B – $5.4B | $4.7B (+3%) | after a round | 3,273 | growing | B | 0% |
| 1 Aug 2025 | $4.7B | $2.9B – $5.5B | $4.7B (0%) | after a round | 3,325 | growing | B | 0% |
| 1 Sep 2025 | $4.7B | $2.9B – $5.5B | $4.7B (0%) | after a round | 3,325 | growing | B | 0% |
| 1 Oct 2025 | $4.8B | $2.7B – $5.5B | $4.8B (0%) | after a round | 3,411 | flat | B | 0% |
| 1 Nov 2025 | $4.8B | $2.6B – $5.5B | $4.8B (0%) | after a round | 3,411 | flat | B | 0% |
| 1 Dec 2025 | $4.8B | $2.5B – $5.5B | $4.8B (0%) | after a round | 3,411 | flat | B | 0% |
| 1 Jan 2026 | $4.8B | $2.4B – $5.5B | $4.8B (0%) | after a round | 3,411 | flat | B | 0% |
| 1 Feb 2026 | $4.8B | $2.3B – $5.5B | $4.8B (0%) | after a round | 3,411 | flat | B | 0% |
| 1 Mar 2026 | $4.8B | $2.2B – $5.5B | $4.8B (0%) | after a round | 3,411 | flat | B | 0% |
| 1 Apr 2026 | $4.9B | $2.9B – $5.6B | $4.9B (0%) | after a round | 3,733 | up | B | 0% |
| 1 May 2026 | $4.9B | $2.9B – $5.6B | $4.9B (0%) | after a round | 3,771 | up | B | 0% |
| 1 Jun 2026 | $4.9B | $2.9B – $5.6B | $4.9B (0%) | after a round | 3,771 | up | B | 0% |
| 1 Jul 2026 | $4.9B | $2.9B – $5.6B | $4.9B (0%) | after a round | 3,771 | up | B | 0% |
| 1 Aug 2026 | $4.9B | $2.6B – $5.6B | $4.9B (0%) | after a round | 3,771 | up | B | 0% |
| 1 Sep 2026 | $4.9B | $2.6B – $5.6B | $4.9B (0%) | after a round | 3,771 | up | B | 0% |
| 1 Oct 2026 | $4.9B | $2.5B – $5.7B | $4.9B (-1%) | after a round | 3,898 | up | B | 0% |
| 24 Oct 2026 | $4.9B | $2.5B – $5.7B | $4.9B (-1%) | after a round | 3,898 | up | B | 0% |
Key facts about Spring Health
- Founded
- 2016
- Headquarters
- New York, United States
- Employees
- about 3,900 +14% in a year
- Total raised
- $464M
- Funding rounds
- 6
- Last round
- Series E Jul 2024
Spring Health was founded in 2016 by Abhishek Chandra, Adam Chekroud and April Koh.
Spring Health funding history
Spring Health has 6 funding rounds on record, from Jul 2018 to Jul 2024, $464M in total. The latest disclosed valuation is $3.30B post-money (Series E, Jul 2024).
Series E 31 Jul 2024
Led by Generation Investment Management; with Kinnevik, William K Warren Foundation, RRE, Northzone.
Sources: springhealth.com, prnewswire.com, bhbusiness.com and 6 more
$100M
$3.30B post-money
Growth Equity 12 Apr 2023
Investors not disclosed.
Sources: bhbusiness.com, beckershospitalreview.com, mobihealthnews.com
$70M
$2.50B post-money
Series C 16 Sep 2021
Led by Kinnevik; with Tiger Global, Northzone, RRE Ventures, Rethink Impact, Work-Bench, William K Warren Foundation, SemperVirens Venture Capital, Able Partners, True Capital Ventures, The Guardian Life Insurance Company of America.
Sources: springhealth.com, mobihealthnews.com, smartbranding.com and 2 more
$190M
$2.00B post-money
Series B 18 Nov 2020
Led by Tiger Global; with Gingerbread Capital, Operator Partners, Northzone, Rethink Impact, William K. Warren Foundation, Work-Bench, SemperVirens Venture Capital, Able Partners, True.
Sources: springhealth.com, prnewswire.com, fiercehealthcare.com and 1 more
$76M
Series A 1 Jan 2020
Led by Northzone; with Equinox Ventures, Able Partners, Fifth Wall, Idinvest Partners, Quadrille Capital, Red Swan Ventures, Sapphire Ventures, Rethink Impact, Work-Bench, RRE, SemperVirens Venture Capital, Warren Foundation. Individuals: alexis bonillo.
Sources: prnewswire.com, fiercehealthcare.com, fiercehealthcare.com
$22M
Seed 12 Jul 2018
Led by Rethink Impact; with Work-Bench, BBG Ventures, Partnership Fund for New York City, RRE, William K. Warren Foundation, Album VC, Bain Capital Ventures, Glade Brook, Kinnevik, Northzone, Oyster Ventures, Pareto Holdings, Sapphire Ventures, Signal Peak Ventures, Soma Capital, Tiger Global, Venture Highway.
Sources: finsmes.com
$6.0M
Spring Health investors
34 investors have backed Spring Health; Northzone, Rethink Impact and Kinnevik and 2 more led at least one round.
- Kinnevik lead, 3 rounds
- Tiger Global lead, 2 rounds
- Generation Investment Management lead
- William K. Warren Foundation 4 rounds
- Sapphire Ventures 2 rounds
- Bain Capital Ventures
- Equinox Ventures
- Fifth Wall
- Glade Brook
- Idinvest Partners
- Oyster Ventures
- RRE Ventures
- Signal Peak Ventures
- Soma Capital
- The Guardian Life Insurance Company of America
- Tiger Global
- True Capital Ventures
- Venture Highway
- Warren Foundation
What Spring Health does
Spring Health works in psychologists & counseling services, with 14 recorded offerings and customers in healthcare and employment services.
Spring Care, Inc., known as Spring Health, is an American company that provides digital mental health solutions, including employee assistance programs, mental health benefits for employers and health plans, and a Continuous Care model. The company offers services such as app-based cognitive exercises, coaching, therapy, and psychiatry, and utilizes proprietary Electronic Health Record (EHR) platforms and machine-learning algorithms to support clinical decision-making and care planning. Spring Health also operates a 24/7 hotline for urgent mental health support and maintains a network of mental healthcare professionals to deliver care and support to individuals and organizations in over 200 countries.
Description from Veridion's company data.
Products and services
- Mental Health Benefits Consulting
- Digital Mental Health Platform Development
- App-Based Cognitive Exercise Services
- Mental Health Coaching Services
- Individual and Group Therapy Services
- Psychiatry Consultation Services
- Electronic Health Record Platform Development
- AI-Driven Clinical Decision Support Solutions
- Personalized Mental Health Care Planning
- Care Navigator Support Services
- Work-Life and Legal Counseling Services
- Financial Counseling Services
- Community Mental Health Engagement Services
- Crisis Intervention Hotline Services
Markets
- Healthcare
- Employment Services
Technology
- AI-Driven Insights for Continuous Care
- Machine Learning for Condition Identification
- Electronic Health Record (EHR) Platform
Business model
- Business-to-Business
- Business-to-Consumer
- Service Provider
- Healthcare
Industry codes (NAICS)
- 621330 Offices of Mental Health Practitioners (except Physicians) 70% match
- 513210 Software Publishers 30% match
Questions about Spring Health
What is Spring Health worth?
Valuation $4.9B (range $2.5B to $5.7B), as of 24 Oct 2026. The last disclosed valuation was $3.30B (Series E, Jul 2024).
Has Spring Health raised money?
Spring Health has 6 funding rounds on record, from Jul 2018 to Jul 2024, $464M in total. The latest disclosed valuation is $3.30B post-money (Series E, Jul 2024).
Who has invested in Spring Health?
Northzone, Rethink Impact, Kinnevik, Tiger Global, Generation Investment Management and William K. Warren Foundation, and 28 more. Lead investors include Northzone, Rethink Impact, Kinnevik and Tiger Global.
How many people work at Spring Health?
About 3,900, up 14% over the last year. Headcount grew from 89 in Jan 2021 to 3,898 in Sep 2026.
What does Spring Health do?
Spring Health works in psychologists & counseling services, with 14 recorded offerings and customers in healthcare and employment services. Its main offerings are mental health benefits consulting, digital mental health platform development and app-based cognitive exercise services.
When was Spring Health founded, and where is it based?
Spring Health was founded in 2016 and is based in New York, United States. It has about 3,900 employees, up 14% over the last year.